Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Case Reports in Oncology
|
June 11, 2020
Associated Myocarditis: A Predictive Factor for Response?
Walid Shalata, Nir Peled, Itzhak Gabizon, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
May 2, 2022
Molecularly Confirmed Female Donor-Transmitted Lobular Breast Cancer to Male following Renal Transplantation
Jonah M Cooper, Benzion Samueli, Elad Mazor, et al.
International Journal of Surgery Case Reports
|
July 24, 2020
Foramen of Winslow hernia years after a Ladd's procedure: A case report
Shadi Abu-Swis, Nir Cohen, Nadav Wallach, et al.
Frontiers in Medicine
|
October 18, 2024
Case report: The efficacy of adding high doses of intravenous vitamin C to the combination therapy of atezolizumab and bevacizumab in unresectable HCC
Waleed Kian, Areen A Remilah, Celine Shatat, et al.
Current Opinion in Oncology
|
October 15, 2021
Lung cancer screening: a critical appraisal
Waleed Kian, Melanie Zemel, Dina Levitas, et al.
Oncology
|
June 9, 2022
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience
Walid Shalata, Alexander Yakobson, Sarah Weissmann, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2022
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination
Walid Shalata, Daniel Levin, Janna Fridman, et al.
Frontiers in Oncology
|
November 28, 2024
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer
Waleed Kian, Belal Krayim, Betsy Giles, et al.
Frontiers in Oncology
|
March 16, 2023
Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib
Waleed Kian, Bilal Krayim, Hadel Alsana, et al.
Clinical Drug Investigation
|
January 19, 2022
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
Vered Fuchs, Waleed Kian, Rachel Lichtenberg, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Case Reports in Oncology
|
June 11, 2020
Associated Myocarditis: A Predictive Factor for Response?
Walid Shalata, Nir Peled, Itzhak Gabizon, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
May 2, 2022
Molecularly Confirmed Female Donor-Transmitted Lobular Breast Cancer to Male following Renal Transplantation
Jonah M Cooper, Benzion Samueli, Elad Mazor, et al.
International Journal of Surgery Case Reports
|
July 24, 2020
Foramen of Winslow hernia years after a Ladd's procedure: A case report
Shadi Abu-Swis, Nir Cohen, Nadav Wallach, et al.
Frontiers in Medicine
|
October 18, 2024
Case report: The efficacy of adding high doses of intravenous vitamin C to the combination therapy of atezolizumab and bevacizumab in unresectable HCC
Waleed Kian, Areen A Remilah, Celine Shatat, et al.
Current Opinion in Oncology
|
October 15, 2021
Lung cancer screening: a critical appraisal
Waleed Kian, Melanie Zemel, Dina Levitas, et al.
Oncology
|
June 9, 2022
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience
Walid Shalata, Alexander Yakobson, Sarah Weissmann, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2022
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination
Walid Shalata, Daniel Levin, Janna Fridman, et al.
Frontiers in Oncology
|
November 28, 2024
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer
Waleed Kian, Belal Krayim, Betsy Giles, et al.
Frontiers in Oncology
|
March 16, 2023
Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib
Waleed Kian, Bilal Krayim, Hadel Alsana, et al.
Clinical Drug Investigation
|
January 19, 2022
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
Vered Fuchs, Waleed Kian, Rachel Lichtenberg, et al.
Page
of 4